Global Geriatric Medicines Market Growth (Status and Outlook) 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Geriatric Medicines Market Size 2017-2028

2.1.2 Geriatric Medicines Market Size CAGR by Region 2017 VS 2022 VS 2028

2.2 Geriatric Medicines Segment by Type

2.2.1 Analgesics

2.2.2 Antihypertensives

2.2.3 Statins

2.2.4 Antidiabetics

2.2.5 Proton Pump Inhibitor

2.2.6 Anticoagulant

2.2.7 Antipsychotics

2.2.8 Antidepressants

2.3 Geriatric Medicines Market Size by Type

2.3.1 Geriatric Medicines Market Size CAGR by Type (2017 VS 2022 VS 2028)

2.3.2 Global Geriatric Medicines Market Size Market Share by Type (2017-2022)

2.4 Geriatric Medicines Segment by Application

2.4.1 Cardiovascular diseases

2.4.2 Arthritis

2.4.3 Neurological Disorders

2.4.4 Cancer

2.4.5 Osteoporosis

2.4.6 Respiratory

2.5 Geriatric Medicines Market Size by Application

2.5.1 Geriatric Medicines Market Size CAGR by Application (2017 VS 2022 VS 2028)

2.5.2 Global Geriatric Medicines Market Size Market Share by Application (2017-2022)

3 Geriatric Medicines Market Size by Player

3.1 Geriatric Medicines Market Size Market Share by Players

3.1.1 Global Geriatric Medicines Revenue by Players (2020-2022)

3.1.2 Global Geriatric Medicines Revenue Market Share by Players (2020-2022)

3.2 Global Geriatric Medicines Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Geriatric Medicines by Regions

4.1 Geriatric Medicines Market Size by Regions (2017-2022)

4.2 Americas Geriatric Medicines Market Size Growth (2017-2022)

4.3 APAC Geriatric Medicines Market Size Growth (2017-2022)

4.4 Europe Geriatric Medicines Market Size Growth (2017-2022)

4.5 Middle East & Africa Geriatric Medicines Market Size Growth (2017-2022)

5 Americas

5.1 Americas Geriatric Medicines Market Size by Country (2017-2022)

5.2 Americas Geriatric Medicines Market Size by Type (2017-2022)

5.3 Americas Geriatric Medicines Market Size by Application (2017-2022)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Geriatric Medicines Market Size by Region (2017-2022)

6.2 APAC Geriatric Medicines Market Size by Type (2017-2022)

6.3 APAC Geriatric Medicines Market Size by Application (2017-2022)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Geriatric Medicines by Country (2017-2022)

7.2 Europe Geriatric Medicines Market Size by Type (2017-2022)

7.3 Europe Geriatric Medicines Market Size by Application (2017-2022)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Geriatric Medicines by Region (2017-2022)

8.2 Middle East & Africa Geriatric Medicines Market Size by Type (2017-2022)

8.3 Middle East & Africa Geriatric Medicines Market Size by Application (2017-2022)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Global Geriatric Medicines Market Forecast

10.1 Global Geriatric Medicines Forecast by Regions (2023-2028)

10.1.1 Global Geriatric Medicines Forecast by Regions (2023-2028)

10.1.2 Americas Geriatric Medicines Forecast

10.1.3 APAC Geriatric Medicines Forecast

10.1.4 Europe Geriatric Medicines Forecast

10.1.5 Middle East & Africa Geriatric Medicines Forecast

10.2 Americas Geriatric Medicines Forecast by Country (2023-2028)

10.2.1 United States Geriatric Medicines Market Forecast

10.2.2 Canada Geriatric Medicines Market Forecast

10.2.3 Mexico Geriatric Medicines Market Forecast

10.2.4 Brazil Geriatric Medicines Market Forecast

10.3 APAC Geriatric Medicines Forecast by Region (2023-2028)

10.3.1 China Geriatric Medicines Market Forecast

10.3.2 Japan Geriatric Medicines Market Forecast

10.3.3 Korea Geriatric Medicines Market Forecast

10.3.4 Southeast Asia Geriatric Medicines Market Forecast

10.3.5 India Geriatric Medicines Market Forecast

10.3.6 Australia Geriatric Medicines Market Forecast

10.4 Europe Geriatric Medicines Forecast by Country (2023-2028)

10.4.1 Germany Geriatric Medicines Market Forecast

10.4.2 France Geriatric Medicines Market Forecast

10.4.3 UK Geriatric Medicines Market Forecast

10.4.4 Italy Geriatric Medicines Market Forecast

10.4.5 Russia Geriatric Medicines Market Forecast

10.5 Middle East & Africa Geriatric Medicines Forecast by Region (2023-2028)

10.5.1 Egypt Geriatric Medicines Market Forecast

10.5.2 South Africa Geriatric Medicines Market Forecast

10.5.3 Israel Geriatric Medicines Market Forecast

10.5.4 Turkey Geriatric Medicines Market Forecast

10.5.5 GCC Countries Geriatric Medicines Market Forecast

10.6 Global Geriatric Medicines Forecast by Type (2023-2028)

10.7 Global Geriatric Medicines Forecast by Application (2023-2028)

11 Key Players Analysis

11.1 Eli Lilly and Company

11.1.1 Eli Lilly and Company Company Information

11.1.2 Eli Lilly and Company Geriatric Medicines Product Offered

11.1.3 Eli Lilly and Company Geriatric Medicines Revenue, Gross Margin and Market Share (2020-2022)

11.1.4 Eli Lilly and Company Main Business Overview

11.1.5 Eli Lilly and Company Latest Developments

11.2 AstraZeneca

11.2.1 AstraZeneca Company Information

11.2.2 AstraZeneca Geriatric Medicines Product Offered

11.2.3 AstraZeneca Geriatric Medicines Revenue, Gross Margin and Market Share (2020-2022)

11.2.4 AstraZeneca Main Business Overview

11.2.5 AstraZeneca Latest Developments

11.3 Boehringer Ingelheim

11.3.1 Boehringer Ingelheim Company Information

11.3.2 Boehringer Ingelheim Geriatric Medicines Product Offered

11.3.3 Boehringer Ingelheim Geriatric Medicines Revenue, Gross Margin and Market Share (2020-2022)

11.3.4 Boehringer Ingelheim Main Business Overview

11.3.5 Boehringer Ingelheim Latest Developments

11.4 Abbott Laboratories

11.4.1 Abbott Laboratories Company Information

11.4.2 Abbott Laboratories Geriatric Medicines Product Offered

11.4.3 Abbott Laboratories Geriatric Medicines Revenue, Gross Margin and Market Share (2020-2022)

11.4.4 Abbott Laboratories Main Business Overview

11.4.5 Abbott Laboratories Latest Developments

11.5 Sanofi

11.5.1 Sanofi Company Information

11.5.2 Sanofi Geriatric Medicines Product Offered

11.5.3 Sanofi Geriatric Medicines Revenue, Gross Margin and Market Share (2020-2022)

11.5.4 Sanofi Main Business Overview

11.5.5 Sanofi Latest Developments

11.6 Bristol-Myers Squibb

11.6.1 Bristol-Myers Squibb Company Information

11.6.2 Bristol-Myers Squibb Geriatric Medicines Product Offered

11.6.3 Bristol-Myers Squibb Geriatric Medicines Revenue, Gross Margin and Market Share (2020-2022)

11.6.4 Bristol-Myers Squibb Main Business Overview

11.6.5 Bristol-Myers Squibb Latest Developments

11.7 Merck

11.7.1 Merck Company Information

11.7.2 Merck Geriatric Medicines Product Offered

11.7.3 Merck Geriatric Medicines Revenue, Gross Margin and Market Share (2020-2022)

11.7.4 Merck Main Business Overview

11.7.5 Merck Latest Developments

11.8 Novartis

11.8.1 Novartis Company Information

11.8.2 Novartis Geriatric Medicines Product Offered

11.8.3 Novartis Geriatric Medicines Revenue, Gross Margin and Market Share (2020-2022)

11.8.4 Novartis Main Business Overview

11.8.5 Novartis Latest Developments

11.9 Pfizer

11.9.1 Pfizer Company Information

11.9.2 Pfizer Geriatric Medicines Product Offered

11.9.3 Pfizer Geriatric Medicines Revenue, Gross Margin and Market Share (2020-2022)

11.9.4 Pfizer Main Business Overview

11.9.5 Pfizer Latest Developments

11.10 GSK

11.10.1 GSK Company Information

11.10.2 GSK Geriatric Medicines Product Offered

11.10.3 GSK Geriatric Medicines Revenue, Gross Margin and Market Share (2020-2022)

11.10.4 GSK Main Business Overview

11.10.5 GSK Latest Developments

12 Research Findings and Conclusion

Table 1. Geriatric Medicines Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)

Table 2. Major Players of Analgesics

Table 3. Major Players of Antihypertensives

Table 4. Major Players of Statins

Table 5. Major Players of Antidiabetics

Table 6. Major Players of Proton Pump Inhibitor

Table 7. Major Players of Anticoagulant

Table 8. Major Players of Antipsychotics

Table 9. Major Players of Antidepressants

Table 10. Geriatric Medicines Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)

Table 11. Global Geriatric Medicines Market Size by Type (2017-2022) & ($ Millions)

Table 12. Global Geriatric Medicines Market Size Market Share by Type (2017-2022)

Table 13. Geriatric Medicines Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)

Table 14. Global Geriatric Medicines Market Size by Application (2017-2022) & ($ Millions)

Table 15. Global Geriatric Medicines Market Size Market Share by Application (2017-2022)

Table 16. Global Geriatric Medicines Revenue by Players (2020-2022) & ($ Millions)

Table 17. Global Geriatric Medicines Revenue Market Share by Player (2020-2022)

Table 18. Geriatric Medicines Key Players Head office and Products Offered

Table 19. Geriatric Medicines Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 20. New Products and Potential Entrants

Table 21. Mergers & Acquisitions, Expansion

Table 22. Global Geriatric Medicines Market Size by Regions 2017-2022 & ($ Millions)

Table 23. Global Geriatric Medicines Market Size Market Share by Regions (2017-2022)

Table 24. Americas Geriatric Medicines Market Size by Country (2017-2022) & ($ Millions)

Table 25. Americas Geriatric Medicines Market Size Market Share by Country (2017-2022)

Table 26. Americas Geriatric Medicines Market Size by Type (2017-2022) & ($ Millions)

Table 27. Americas Geriatric Medicines Market Size Market Share by Type (2017-2022)

Table 28. Americas Geriatric Medicines Market Size by Application (2017-2022) & ($ Millions)

Table 29. Americas Geriatric Medicines Market Size Market Share by Application (2017-2022)

Table 30. APAC Geriatric Medicines Market Size by Region (2017-2022) & ($ Millions)

Table 31. APAC Geriatric Medicines Market Size Market Share by Region (2017-2022)

Table 32. APAC Geriatric Medicines Market Size by Type (2017-2022) & ($ Millions)

Table 33. APAC Geriatric Medicines Market Size Market Share by Type (2017-2022)

Table 34. APAC Geriatric Medicines Market Size by Application (2017-2022) & ($ Millions)

Table 35. APAC Geriatric Medicines Market Size Market Share by Application (2017-2022)

Table 36. Europe Geriatric Medicines Market Size by Country (2017-2022) & ($ Millions)

Table 37. Europe Geriatric Medicines Market Size Market Share by Country (2017-2022)

Table 38. Europe Geriatric Medicines Market Size by Type (2017-2022) & ($ Millions)

Table 39. Europe Geriatric Medicines Market Size Market Share by Type (2017-2022)

Table 40. Europe Geriatric Medicines Market Size by Application (2017-2022) & ($ Millions)

Table 41. Europe Geriatric Medicines Market Size Market Share by Application (2017-2022)

Table 42. Middle East & Africa Geriatric Medicines Market Size by Region (2017-2022) & ($ Millions)

Table 43. Middle East & Africa Geriatric Medicines Market Size Market Share by Region (2017-2022)

Table 44. Middle East & Africa Geriatric Medicines Market Size by Type (2017-2022) & ($ Millions)

Table 45. Middle East & Africa Geriatric Medicines Market Size Market Share by Type (2017-2022)

Table 46. Middle East & Africa Geriatric Medicines Market Size by Application (2017-2022) & ($ Millions)

Table 47. Middle East & Africa Geriatric Medicines Market Size Market Share by Application (2017-2022)

Table 48. Key Market Drivers & Growth Opportunities of Geriatric Medicines

Table 49. Key Market Challenges & Risks of Geriatric Medicines

Table 50. Key Industry Trends of Geriatric Medicines

Table 51. Global Geriatric Medicines Market Size Forecast by Regions (2023-2028) & ($ Millions)

Table 52. Global Geriatric Medicines Market Size Market Share Forecast by Regions (2023-2028)

Table 53. Global Geriatric Medicines Market Size Forecast by Type (2023-2028) & ($ Millions)

Table 54. Global Geriatric Medicines Market Size Market Share Forecast by Type (2023-2028)

Table 55. Global Geriatric Medicines Market Size Forecast by Application (2023-2028) & ($ Millions)

Table 56. Global Geriatric Medicines Market Size Market Share Forecast by Application (2023-2028)

Table 57. Eli Lilly and Company Details, Company Type, Geriatric Medicines Area Served and Its Competitors

Table 58. Eli Lilly and Company Geriatric Medicines Product Offered

Table 59. Eli Lilly and Company Geriatric Medicines Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 60. Eli Lilly and Company Main Business

Table 61. Eli Lilly and Company Latest Developments

Table 62. AstraZeneca Details, Company Type, Geriatric Medicines Area Served and Its Competitors

Table 63. AstraZeneca Geriatric Medicines Product Offered

Table 64. AstraZeneca Main Business

Table 65. AstraZeneca Geriatric Medicines Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 66. AstraZeneca Latest Developments

Table 67. Boehringer Ingelheim Details, Company Type, Geriatric Medicines Area Served and Its Competitors

Table 68. Boehringer Ingelheim Geriatric Medicines Product Offered

Table 69. Boehringer Ingelheim Main Business

Table 70. Boehringer Ingelheim Geriatric Medicines Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 71. Boehringer Ingelheim Latest Developments

Table 72. Abbott Laboratories Details, Company Type, Geriatric Medicines Area Served and Its Competitors

Table 73. Abbott Laboratories Geriatric Medicines Product Offered

Table 74. Abbott Laboratories Main Business

Table 75. Abbott Laboratories Geriatric Medicines Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 76. Abbott Laboratories Latest Developments

Table 77. Sanofi Details, Company Type, Geriatric Medicines Area Served and Its Competitors

Table 78. Sanofi Geriatric Medicines Product Offered

Table 79. Sanofi Main Business

Table 80. Sanofi Geriatric Medicines Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 81. Sanofi Latest Developments

Table 82. Bristol-Myers Squibb Details, Company Type, Geriatric Medicines Area Served and Its Competitors

Table 83. Bristol-Myers Squibb Geriatric Medicines Product Offered

Table 84. Bristol-Myers Squibb Main Business

Table 85. Bristol-Myers Squibb Geriatric Medicines Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 86. Bristol-Myers Squibb Latest Developments

Table 87. Merck Details, Company Type, Geriatric Medicines Area Served and Its Competitors

Table 88. Merck Geriatric Medicines Product Offered

Table 89. Merck Main Business

Table 90. Merck Geriatric Medicines Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 91. Merck Latest Developments

Table 92. Novartis Details, Company Type, Geriatric Medicines Area Served and Its Competitors

Table 93. Novartis Geriatric Medicines Product Offered

Table 94. Novartis Main Business

Table 95. Novartis Geriatric Medicines Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 96. Novartis Latest Developments

Table 97. Pfizer Details, Company Type, Geriatric Medicines Area Served and Its Competitors

Table 98. Pfizer Geriatric Medicines Product Offered

Table 99. Pfizer Main Business

Table 100. Pfizer Geriatric Medicines Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 101. Pfizer Latest Developments

Table 102. GSK Details, Company Type, Geriatric Medicines Area Served and Its Competitors

Table 103. GSK Geriatric Medicines Product Offered

Table 104. GSK Main Business

Table 105. GSK Geriatric Medicines Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 106. GSK Latest Developments

List of Figures

Figure 1. Geriatric Medicines Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global Geriatric Medicines Market Size Growth Rate 2017-2028 ($ Millions)

Figure 6. Global Geriatric Medicines Market Size Market Share by Type in 2021

Figure 7. Geriatric Medicines in Cardiovascular diseases

Figure 8. Global Geriatric Medicines Market: Cardiovascular diseases (2017-2022) & ($ Millions)

Figure 9. Geriatric Medicines in Arthritis

Figure 10. Global Geriatric Medicines Market: Arthritis (2017-2022) & ($ Millions)

Figure 11. Geriatric Medicines in Neurological Disorders

Figure 12. Global Geriatric Medicines Market: Neurological Disorders (2017-2022) & ($ Millions)

Figure 13. Geriatric Medicines in Cancer

Figure 14. Global Geriatric Medicines Market: Cancer (2017-2022) & ($ Millions)

Figure 15. Geriatric Medicines in Osteoporosis

Figure 16. Global Geriatric Medicines Market: Osteoporosis (2017-2022) & ($ Millions)

Figure 17. Geriatric Medicines in Respiratory

Figure 18. Global Geriatric Medicines Market: Respiratory (2017-2022) & ($ Millions)

Figure 19. Global Geriatric Medicines Market Size Market Share by Application in 2021

Figure 20. Global Geriatric Medicines Revenue Market Share by Player in 2021

Figure 21. Global Geriatric Medicines Market Size Market Share by Regions (2017-2022)

Figure 22. Americas Geriatric Medicines Market Size 2017-2022 ($ Millions)

Figure 23. APAC Geriatric Medicines Market Size 2017-2022 ($ Millions)

Figure 24. Europe Geriatric Medicines Market Size 2017-2022 ($ Millions)

Figure 25. Middle East & Africa Geriatric Medicines Market Size 2017-2022 ($ Millions)

Figure 26. Americas Geriatric Medicines Value Market Share by Country in 2021

Figure 27. Americas Geriatric Medicines Consumption Market Share by Type in 2021

Figure 28. Americas Geriatric Medicines Market Size Market Share by Application in 2021

Figure 29. United States Geriatric Medicines Market Size Growth 2017-2022 ($ Millions)

Figure 30. Canada Geriatric Medicines Market Size Growth 2017-2022 ($ Millions)

Figure 31. Mexico Geriatric Medicines Market Size Growth 2017-2022 ($ Millions)

Figure 32. Brazil Geriatric Medicines Market Size Growth 2017-2022 ($ Millions)

Figure 33. APAC Geriatric Medicines Market Size Market Share by Region in 2021

Figure 34. APAC Geriatric Medicines Market Size Market Share by Application in 2021

Figure 35. China Geriatric Medicines Market Size Growth 2017-2022 ($ Millions)

Figure 36. Japan Geriatric Medicines Market Size Growth 2017-2022 ($ Millions)

Figure 37. Korea Geriatric Medicines Market Size Growth 2017-2022 ($ Millions)

Figure 38. Southeast Asia Geriatric Medicines Market Size Growth 2017-2022 ($ Millions)

Figure 39. India Geriatric Medicines Market Size Growth 2017-2022 ($ Millions)

Figure 40. Australia Geriatric Medicines Market Size Growth 2017-2022 ($ Millions)

Figure 41. Europe Geriatric Medicines Market Size Market Share by Country in 2021

Figure 42. Europe Geriatric Medicines Market Size Market Share by Type in 2021

Figure 43. Europe Geriatric Medicines Market Size Market Share by Application in 2021

Figure 44. Germany Geriatric Medicines Market Size Growth 2017-2022 ($ Millions)

Figure 45. France Geriatric Medicines Market Size Growth 2017-2022 ($ Millions)

Figure 46. UK Geriatric Medicines Market Size Growth 2017-2022 ($ Millions)

Figure 47. Italy Geriatric Medicines Market Size Growth 2017-2022 ($ Millions)

Figure 48. Russia Geriatric Medicines Market Size Growth 2017-2022 ($ Millions)

Figure 49. Middle East & Africa Geriatric Medicines Market Size Market Share by Region in 2021

Figure 50. Middle East & Africa Geriatric Medicines Market Size Market Share by Type in 2021

Figure 51. Middle East & Africa Geriatric Medicines Market Size Market Share by Application in 2021

Figure 52. Egypt Geriatric Medicines Market Size Growth 2017-2022 ($ Millions)

Figure 53. South Africa Geriatric Medicines Market Size Growth 2017-2022 ($ Millions)

Figure 54. Israel Geriatric Medicines Market Size Growth 2017-2022 ($ Millions)

Figure 55. Turkey Geriatric Medicines Market Size Growth 2017-2022 ($ Millions)

Figure 56. GCC Country Geriatric Medicines Market Size Growth 2017-2022 ($ Millions)

Figure 57. Americas Geriatric Medicines Market Size 2023-2028 ($ Millions)

Figure 58. APAC Geriatric Medicines Market Size 2023-2028 ($ Millions)

Figure 59. Europe Geriatric Medicines Market Size 2023-2028 ($ Millions)

Figure 60. Middle East & Africa Geriatric Medicines Market Size 2023-2028 ($ Millions)

Figure 61. United States Geriatric Medicines Market Size 2023-2028 ($ Millions)

Figure 62. Canada Geriatric Medicines Market Size 2023-2028 ($ Millions)

Figure 63. Mexico Geriatric Medicines Market Size 2023-2028 ($ Millions)

Figure 64. Brazil Geriatric Medicines Market Size 2023-2028 ($ Millions)

Figure 65. China Geriatric Medicines Market Size 2023-2028 ($ Millions)

Figure 66. Japan Geriatric Medicines Market Size 2023-2028 ($ Millions)

Figure 67. Korea Geriatric Medicines Market Size 2023-2028 ($ Millions)

Figure 68. Southeast Asia Geriatric Medicines Market Size 2023-2028 ($ Millions)

Figure 69. India Geriatric Medicines Market Size 2023-2028 ($ Millions)

Figure 70. Australia Geriatric Medicines Market Size 2023-2028 ($ Millions)

Figure 71. Germany Geriatric Medicines Market Size 2023-2028 ($ Millions)

Figure 72. France Geriatric Medicines Market Size 2023-2028 ($ Millions)

Figure 73. UK Geriatric Medicines Market Size 2023-2028 ($ Millions)

Figure 74. Italy Geriatric Medicines Market Size 2023-2028 ($ Millions)

Figure 75. Russia Geriatric Medicines Market Size 2023-2028 ($ Millions)

Figure 76. Spain Geriatric Medicines Market Size 2023-2028 ($ Millions)

Figure 77. Egypt Geriatric Medicines Market Size 2023-2028 ($ Millions)

Figure 78. South Africa Geriatric Medicines Market Size 2023-2028 ($ Millions)

Figure 79. Israel Geriatric Medicines Market Size 2023-2028 ($ Millions)

Figure 80. Turkey Geriatric Medicines Market Size 2023-2028 ($ Millions)

Figure 81. GCC Countries Geriatric Medicines Market Size 2023-2028 ($ Millions)